SUPER DONOR
DEAD

Serial Number

79268398

Owner

MYBIOTICS PHARMA LTD

Attorney

Yael Rouach Cabilly

Filing Date

Jul 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SUPER DONOR Trademark

Serial Number: 79268398

SUPER DONOR is a trademark filed by MYBIOTICS PHARMA LTD on July 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

MYBIOTICS PHARMA LTD (4 trademarks)

2 Ilan Ramon

Entity Type: 16

Trademark Details

Filing Date

July 15, 2019

Registration Date

Not Registered

Goods & Services

Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks in the nature of powdered and ready-to-drink beverages; dietary food supplements; dietary supplement drink mixes; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; nonprescription medicine, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders, non-medicated topical gel for the prevention and treatment of allergies, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria, for the prevention and treatment of bacterial vaginosis and related women health disorders, for supporting oncology treatments, antibiotic associated diarrhea; medicines for dental purposes; medicines for veterinary purposes, namely, antioxidants, veterinary preparations for treatment of intestinal bacteria; pain relief medication; decongestant capsules; herbal medicines being medicinal herbal preparations; antihypertensives; antitussives; diarrhea medication; antiflatulents; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 2, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 2, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 20, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 3, 2021 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 2, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 2, 2020 ABN2
REFUSAL PROCESSED BY IB
Jun 26, 2020 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2020 TROA
REFUSAL PROCESSED BY IB
Nov 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 9, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 8, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
ASSIGNED TO EXAMINER
Oct 4, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 26, 2019 REPR